Nonetheless, there is compelling evidence indicating that following the introduction of prostate-specific antigen testing, mortality rates tended to rise among men residing in rural areas who had been diagnosed with prostate cancer [10]. The gene discussed is KLK3; the disease is prostate carcinoma.